STRO Stock Analysis: Buy, Sell, or Hold?
STRO - Sutro Biopharma, Inc.
$14.95
0.03 (0.20%)
▲
5d:
-0.66%
30d:
+28.11%
90d:
+1323.81%
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 12, 2026
Get Alerted When STRO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: STRO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: STRO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: STRO is currently trading at $14.95, which is considered slightly high relative to its 30-day fair value range of $11.20 to $15.15.
Technical Outlook: Technically, STRO is in a strong uptrend. Immediate support is located at $12.59, while resistance sits at $17.33.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $2.69. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, STRO is in a strong uptrend. Immediate support is located at $12.59, while resistance sits at $17.33.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $2.69. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$11.20 -
$15.15
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
56.3%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 82.0% above Wall St target ($2.69)
Fair Price Analysis
30-Day Fair Range
$11.20 -
$15.15
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$12.59
Resistance Level
$17.33
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-12.78
Wall Street Target
$2.69
(-82.0%)
Revenue Growth (YoY)
13.8%
Profit Margin
-205.2%
Last updated: February 02, 2026 4:05 AM ET
Data refreshes hourly during market hours. Next update: 5:05 AM
Data refreshes hourly during market hours. Next update: 5:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STRO showing a specific setup today?
Insider Activity (6 Months)
5
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Connie Matsui
BUY
50000 shares
2025-10-15
David Pauling
BUY
12504 shares
2025-10-15
Gregory K Chow
BUY
19750 shares
2025-10-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$93 | 59 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$34 | 51 HOLD |
|
MRNA
Moderna Inc |
SELL
27 analysts |
$39 | 59 HOLD |
